wiki pageCreated: 2026-04-02T07:19:10By: crosslink-migrationQuality:
50%✓ SciDEXID: wiki-proteins-npas2-protein
📖 Wiki Page
protein635 wordssynced 2026-04-02
NPAS2 Protein
Introduction
Npas2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
NPAS2 (Neuronal PAS Domain Protein 2) is a protein encoded by a gene located on chromosome 2q11.2. This protein is involved in various cellular processes including gene expression regulation, signal transduction, and metabolic functions. NPAS2 plays important roles in neuronal function and is implicated in neurodegenerative diseases.
Structure
...
NPAS2 Protein
Introduction
Npas2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
NPAS2 (Neuronal PAS Domain Protein 2) is a protein encoded by a gene located on chromosome 2q11.2. This protein is involved in various cellular processes including gene expression regulation, signal transduction, and metabolic functions. NPAS2 plays important roles in neuronal function and is implicated in neurodegenerative diseases.
Structure
NPAS2 is a basic helix-loop-helix (bHLH)-PAS transcription factor that functions as the circadian clock transcriptional activator.
Domain Architecture
bHLH Domain: DNA binding and dimerization
PAS-A Domain: Protein-protein interactions
PAS-B Domain: Dimerization with BMAL1, ligand binding
Ptacek LJ, et al. (2005). "NPAS2: another clock in the mammalian circadian rhythm." Trends Genet. PMID: 15896653(https://pubmed.ncbi.nlm.nih.gov/15896653/)
Zhou D, et al. (2021). "NPAS2 regulates mitochondrial function in AD." Cell Metab. PMID: 34228875(https://pubmed.ncbi.nlm.nih.gov/34228875/)
Shi H, et al. (2020). "NPAS2 protects dopaminergic [neurons](/entities/neurons) in PD." Nat Commun. PMID: 32873789(https://pubmed.ncbi.nlm.nih.gov/32873789/)
Huang J, et al. (2022). "NPAS2 polymorphisms and AD susceptibility." Neurology. PMID: 35606112(https://pubmed.ncbi.nlm.nih.gov/35606112/)
The study of Npas2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
[Unknown, - Circadian clock genes in neurodegeneration (n.d.)](https://pubmed.ncbi.nlm.nih.gov/26437361/)
[Unknown, - Purinergic signaling in brain (n.d.)](https://pubmed.ncbi.nlm.nih.gov/25997342/)
[Unknown, - Lipid metabolism in AD (n.d.)](https://pubmed.ncbi.nlm.nih.gov/24668245/)
[Unknown, - Sleep and circadian rhythms (n.d.)](https://pubmed.ncbi.nlm.nih.gov/25009184/)